MedTrace Logo

Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension

NCT01515865 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2021-06-09

Study results available
· View outcomes & findings →

Summary

To study the effect of midodrine against the symptoms of orthostatic hypotension

Conditions

  • Symptomatic Orthostatic Hypotension

Interventions

DRUG

Midodrine HCl

dose at subject's current dose level

DRUG

Placebo

single dose of matching placebo

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-23
Primary Completion
2013-11-11
Completion
2013-11-11

Countries

  • United States
  • Czechia
  • Poland
  • Slovakia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01515865 on ClinicalTrials.gov